Welcome reception will be held in the National Kazakh Abay Restaurant. It is located on the mountain Kok Tobe, in one of the most beautiful places of the city of Almaty at an altitude of 1100 meters.
Address: Almaty, 050010, Dostyk pr. 104B.
A shuttle service from Rixos Almaty to the venue and back will be arranged for participants.

Moderator: VYACHESLAV LOKSHIN, President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

• Current development strategies of pharmaceutical companies. Specifics of work in different markets of the region, considering peculiarities of pricing regulation, registration requirements, introduction of labelling procedures, transport and logistics infrastructures
• Drivers of growth of the pharmaceutical market in the Eurasian region
• Areas of regulatory support to address the challenge of uninterrupted drug supply
• What plans do international pharmaceutical companies have to localize and deepen production?
• Effective cross-national co-operation between pharmaceutical manufacturers in the Eurasian region

Speakers:
NAZERKE BALTAEVA, Head of the Department for Validation of Medicines Registration Dossier Materials of the Department of Medicines Expertise, “National Center for the Expertise of Medicines and Medical Devices” of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan
DMITRY GRINKO, Director, Center for Expertise and Testing in Healthcare of the Republic of Belarus
TATIANA DENISIK, Deputy Head of the Department for Organization of Drug Supply of the Ministry of Health of the Republic of Belarus
AKZHOLTOY BOLOTBEKOVA, acting Head of the Sector for EAEU Issues of the Department of Medicines and Medical Devices under the Ministry of Health of the Kyrgyz Republic
TATEVIK YERITSYAN, Coordinator for the circulation of medicines and medical devices within the EAEU, Scientific Center for Expertise of Medicines and Medical Technologies named after. Academician Emil Gabrielyan"
ELENA POPOVA, Senior Director for Regulatory Affairs and Healthcare, Association of International Pharmaceutical Manufacturers, Ph.D.
Confirmation awaited:
NURLAN ISKAKOV, Chairman, Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan
Representative of the Eurasian Economic Commission

Moderator: VYACHESLAV LOKSHIN, President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

• Review of key changes regarding the regulation of pharmaceutical activities in the common economic space
• Optimization of the procedure for bringing previously registered medicinal products into compliance with Union law
• Ongoing work to simplify re-authorization and dossier matching procedures
• Conditions for accelerated expert examination in the course of registration of medicinal products
• Prospects for addressing issues of integration interaction between Member States in mutual recognition of registration procedures
• The strategy of the common market of medicines of the EAEU - the vision of the regulators in the future. Concept for the further development of a common market for medicines within the Union - what steps should be taken first?
• Collaboration on information exchange between country regulators and drug manufacturers

Speakers:
YERKIN DAUTBAYEV, General Director - Chairman of the Board of RGP for PCB «National Center for Examination of Medicines and Medical Products» of the Medical and Pharmaceutical Control Committee of the Ministry of Health of the Republic of Kazakhstan.
TATIANA DENISIK, Deputy Directorate of Drug Organization of the Ministry of Health of the Republic of Belarus
TATEVIK ERICYAN, coordinator on the issues of treatment of medicines and medical products within the EAEU, «Scientific center of examination of medicines and medical technologies. Academician Emil Gabrielian»
To be confirmed:
NURLAN ISKAKOV, Chairman, Medical and Pharmaceutical Control Committee of the Ministry of Health of the Republic of Kazakhstan
KENZHEBEK TULESHOV, Head of the Department of Public Services in the field of circulation of medicines and medical devices, Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan

Moderator: MARINA DURMANOVA, President, Association for Support and Development of Pharmaceutical Activity of the Republic of Kazakhstan

• Practical application of pricing mechanisms and approaches to price regulation in the countries of the Eurasian region
• Differences in methods of price regulation as a factor in the development of market imbalances
• The problem of sharing the information needed to fulfil the price comparison mechanism
• Evolution of deregulation: the experience of phased deregulation of over-the-counter drug prices in the Republic of Kazakhstan

Speakers
MARAT OMAROV, Chairman, Agency for Protection and Development of Competition of the Republic of Kazakhstan
AGZAM NARTAEV, Director, “Center for Safety of Pharmaceutical Products” of the Ministry of Health of the Republic of Uzbekistan
NELLY KANDORA, Head of the Medicines Price Registration Sector of the Medicines Administration, Center for Expertise and Testing in Healthcare of the Republic of Belarus
OLGA KOROLKOVA, Deputy Director of the Antimonopoly Regulation Department, Eurasian Economic Commission (online)
AISHA SULAIMANOVA, Head of the Pricing and Monitoring Department of the Department of Medicines and Medical Devices under the Ministry of Health of the Kyrgyz Republic
OLEG KASPAROV, Head of the CIS Cluster, Bayer
ALEXEY KEDRIN, Chairman of the Board of the Association of Pharmaceutical Manufacturers of the EAEU
VILENA GALKINA, Director of Government Relations, Geropharm
ZAFAR VAKHIDOV, partner, Vakhidov & Partners
Confirmation awaited:
KENZHEBEK TULESHOV, Head of the Department of Public Services in the field of circulation of medicines and medical devices, Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan

Speaker:
 LARISA EMELYANOVA, senior lawyer, law firm AEQUITAS.

• The need to reduce the time and increase the volume of patient access to innovative drugs
• Key challenges in bringing an innovative drug to emerging markets and possible solutions
• Development of innovative drug supply – an investment in the future of a sustainable healthcare system

Speakers:
ANNA DRELICH, Head of Pricing, Market Access and Tender Channel, Bayer Kazakhstan
ANDREY IVANOV, Head of Market Access Department, AstraZeneca in Kazakhstan
ALEXANDER KOSTYUK, independent expert on drug policy and health technology assessment
ANNA LAKHTANOVA, Chairman of the Regulatory Committee, Association of International Pharmaceutical Manufacturers
NATALIA MUEVA, Director of Medical Programs, Aston Health

Moderator: VADIM KUKAVA, Executive Director, Association of Pharmaceutical Companies “Pharmaceutical Innovations” (“Inpharma”)

• Development of the Eurasian patent system. Eurasian Patent Pharmaceutical Register
• Can “patent linkage” serve as a tool to provide transparency regarding patent-protected inventions and legal certainty in the registration process of reproduced medicinal products and biosimilars?
• Approaches to creating and protecting a patent portfolio in the countries of the Eurasia region
• Challenges of entering the market after patent expiration (Day One Launch Doctrine)

Speakers:
DARIA RUBAILO, Chief Expert of the Department of Chemistry and Medicine, Eurasian Patent Office (EAPO) of the Eurasian Patent Organization
BEKHZOD RUZIEV, Head of the Department of Intellectual Property Protection, Ministry of Justice of the Republic of Uzbekistan
VIKTOR DMITRIEV, Chairman of the Public Council under Roszdravnadzor, General Director of ARPP
RAVIL KASSILGOV, partner, Tukulov Kassilgov Shaikenov Disputes
NATALIA SHAPOVALOVA, Partner, "Triay"
Representative of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan
KENZHEBEK TULESHOV, Head of the Department of Public Services in the field of circulation of medicines and medical devices, Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan

Moderator: VADIM KUKAVA, Executive Director, Association of Pharmaceutical Companies “Pharmaceutical Innovations” (“Inpharma”)

During the session, we will discuss the recognition of a medicinal product of particular importance for public health. Prospects for establishing uniform approaches to the practice of drug selection in the EAEU member states. What benefits will this status bring in the future, apart from accelerated registration - inclusion in lists and programs of preferential medicine provision, pricing, special conditions for participation in tendering?

Speakers:
GULNARA KULKAEVA, Chairman of the Board, RGP on PCB «Salidat Kairbekova National Scientific Center for Health Development»
VITALY OMELIANOVSKY, General Director of FSBU «Center of Expertise and Quality Control of Medical Care» of the Ministry of Health of the Russian Federation
ALEXANDER KOSTYUK, independent expert on drug policy and health technology assessment
ALEXANDER MARTYNENKO, Director of Industrial Policy, Association of International Pharmaceutical Manufacturers

Speakers:.
 GALYMZHAN KOZHAKANOV, Head of Representative Office «SANDOZ PHARMACEUTICALS D.D» in the Republic of Kazakhstan - Chairman of the Ethical Committee, Association of International Pharmaceutical Producers in the Republic of Kazakhstan
 VYACHESLAV LOKSHIN, President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

During the session, we will analyze the dynamics of the pharmaceutical markets in the Eurasian region as a whole and in various segments, identify growth drivers, assess investment attractiveness and make forecasts for future development.

Speakers:
NIKITA KORSHIKOV, engagement manager consulting Russia/Cis, IQVIA
ALEXANDER IVANOV, Head of Strategic Consulting, Aston Health
TIMUR LIVAZOV, business partner of the Pharma and FMCG industries. Yandex.Kazakhstan
VALENTINA MARCHENKOVA, founder, Sirius Group of Companies
ANNA KIM, commercial director, Pharma Choice

Moderator: ZAFAR VAKHIDOV, partner, Vakhidov & Partners

• Trends in the legislative system of public procurement
• Development of a system of long-term contracts
• Innovative model of drug provision in modern conditions
• Centralization of procurement in various therapeutic areas

Speakers:
TATIANA DENISIK, Deputy Head of the Drug Supply Organization of the Ministry of Health of the Republic of Belarus
ABDULLAH AZIZOV, Director, Agency for Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan
ERIKBEK AGATANOV, Executive Director, Karaganda Pharmaceutical Complex
BATYRBEK MASHKEV, General Director, Viva-Pharm
TATIANA TRUKHAN, Secretary of the Commission for Priority Procurement of the Ministry of Health of the Republic of Belarus, Head of the Competitive Bidding and Procurement Group of the Marketing, Foreign Economic Activity and Tender Procurement Department of RUE "Belpharmacy"

Moderator: OLZHAS SATYBALDIN, Head of Department for Work with Government Authorities, AstraZeneca

• How do states encourage localization and how do business representatives view investment attractiveness?
• What is the feasibility of localization for pharmaceutical companies? Analysis of issues ranging from preferential access to government procurement to the export of drugs to EAEU countries.
• Approaches to localization: creation of own site or joint investment in existing facilities of local companies
• Improving the company's efficiency by introducing advanced practices and production technologies

Speakers:
ABDULLAH AZIZOV, Agency for  development of the pharmaceutical industry under the Ministry of Health of the Republic of Uzbekistan
VILENA GALKINA, Director for Relations with Government Authorities, Geropharm
DZHAN TANZHARYKOV, Head of Department for  work with domestic producers and work with international organizations, SK-Pharmacia
LILIYA TITOVA, Executive Director of the Union of Professional Pharmaceutical Organizations
PAVEL KHEGAI, General Director, Gedeon Richter Kazakhstan and   Director of Business Development for the CIS Region, Gedeon Richter

Moderator: MARIA FEDOROVA, Director, Clinical trial support

• Current state of the clinical trials market in the Eurasian region
• Regulatory framework for the development of clinical trials
• Possibility of inspecting EAEU clinical sites
• Prospects for mutual recognition of clinical trial results within the framework of the integration process
• Field inspection methodology for clinical trials within the EAEU

Speakers:
NADEZHDA TIKHONOVA, Senior Director of Clinical Research, AstraZeneka Russia and Eurasia
MARGARITA GRAF, Head of Clinical Research Development Center, RGP on PCB «Salidat Kairbekova National Scientific Center for Health Development»
DMITRY BOGDAN, Director of Clinical and Regulatory Operations, Smooth Drug Development
IRINA KIM, independent expert, member of the working group on harmonization of regulations

Moderator: EKATERINA YAKOVLEVA, Head of Quality Group, AstraZeneca Russia and Eurasia

• Current readiness of pharmaceutical manufacturers in the EAEU member states to implement GMP standards
• Inspection of drug manufacturing for compliance with the EAEU rules – work to harmonize approaches
• Current approaches and opportunities for cooperation
• Mutual recognition issues

Speakers:
AZIZ DUSMATOV, Director of «Center of Good Practices» Pharmaceutical Industry Development Agency under the Ministry of Health of the Republic of Uzbekistan
FARIDA MAKEEVA, Head of Inspection Department, RGP for PCB «National Center for Examination of Medicines and Medical Products» of the Medical and Pharmaceutical Control Committee of the Ministry of Health of the Republic of Kazakhstan
TALENT DUSHEMBIEV, Chief Specialist of the Pharmaceutical Inspection Department of the Department of Medicines and Medical Products under the Ministry of Health of the Kyrgyz Republic
IRINA SPICHAK, Executive Director of the Eurasian Academy of Good Practices, Doctor of Pharmaceutical Sciences, Professor
MKRTYCH SHAKARYAN, Head of the Department of Good Pharmaceutical Practice, “Scientific Center for Expertise of Medicines and Medical Technologies named after Academician Emil Gabrielyan”
ELENA POPOVA, Senior Director for Regulatory Affairs and Healthcare, Association of International Pharmaceutical Manufacturers

• Current consideration and prospects for the adoption of the Concept of Development of Approaches to Collection, Analysis and Use of Real Clinical Practice Data in the Circulation of Medicines in the EAEU member states
• Opportunities to use RWD/RWE for the registration of new medicines and to speed up the launch of innovative and orphan medicines, as well as in the post-marketing period.
• Global experience in using data from real clinical practice and the ability to implement best practices

Speaker:
ALEXEY KOLBIN, Head of the Department of Clinical Pharmacology and Evidence Medicine of the First St.-Petersburg State Medical University. Akad. I.P. Pavlova, Ph.D.
ALEXANDER SALODOVNIKOV, Director of Quality Management, Statandocs
VADIM KUKAVA, Executive Director, Association of Pharmaceutical Companies «Pharmaceutical Innovations» («Infrara»)

• Current status and main directions of digitalization in healthcare
• The role of the pharmaceutical industry in the development of digitalization trends, particularly in terms of the use of AI and the collection of big data.
• What areas of interaction/partnership with the pharmaceutical industry exist now and may exist in the future?

Speaker:
SVETLANA NIKINEN, Director of Registration, AstraZeneka Russia and Eurasia
TATIANA DENISIK, Deputy Head of the Drug Supply Organization of the Ministry of Health of the Republic of Belarus
ABDULLAH AZIZOV, Director, Agency for Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan

• Risk Management Plan (RMP) – when it's needed, when it needs to be updated
• Summary of the risk management plan as a document publicly available in the Union’s information systems

Speaker:
EKATERINA SOROKINA, Director, Statandocs

Moderator: MARINA DURMANOVA, President, Association for Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan

• Current status of the labeling implementation process in the countries of the region
• Key challenges facing the industry and ways to overcome them
• Unification of approaches to labeling on the territory of the EAEU
• Measures to ensure traceability and transparency of cross-border trade

Speakers:
ALEXEY KOSAREV, Project Manager of the «Pharma» Advanced Technologies Development Center (CPCP) - Operator of the state labeling system «Honest Sign»
BICESH KURMANGALIYEVA, General Director of the Project Office of the Single Operator of Marking and Traceability of Goods in the Republic of Kazakhstan
ALEXANDER CHERNICHENKO, CEO of «Meuse Media»